| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DNER FLG2 STAB1 SNED1 FBLN1 MEGF6 MEGF8 OTOF TKT LOXL2 LRP4 ADGRE5 MYL10 FBN3 NOTCH4 | 7.62e-06 | 749 | 104 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | Notch binding | 3.67e-04 | 27 | 104 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.13e-04 | 120 | 104 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PCSK5 HGFAC TMPRSS11E ADAMTS10 ADAMTS6 ADAMTS9 PCSK6 ADAMTS16 ADAMTS20 | 4.14e-04 | 430 | 104 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.55e-04 | 31 | 104 | 3 | GO:0030247 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | CARMIL2 ADAMTSL3 ADAMTS10 FBLN1 ADAMTS6 ADAMTS9 LOXL2 WNT3A ADAMTS16 ADAMTS20 | 1.93e-05 | 377 | 103 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | CARMIL2 ADAMTSL3 ADAMTS10 FBLN1 ADAMTS6 ADAMTS9 LOXL2 WNT3A ADAMTS16 ADAMTS20 | 1.97e-05 | 378 | 103 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | CARMIL2 ADAMTSL3 ADAMTS10 FBLN1 ADAMTS6 ADAMTS9 LOXL2 WNT3A ADAMTS16 ADAMTS20 | 2.02e-05 | 379 | 103 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ERBB4 RPGRIP1L HYAL1 WNT6 NTN3 GATA6 NDP GATA5 ZFPM1 IRX4 LHX9 ENAM GRXCR2 MEGF8 ADAMTS9 WNT3A ADAMTS16 LRP4 | 5.26e-05 | 1269 | 103 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | tube development | PCSK5 FNDC3B RPGRIP1L THSD7A HYAL1 WNT6 GATA6 CARD10 NDP GATA5 STAB1 MEGF8 ADAMTS9 LOXL2 WNT3A SCAPER ADAMTS16 COBL NOTCH4 | 5.86e-05 | 1402 | 103 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | pattern specification process | PCSK5 ERBB4 RPGRIP1L WNT6 GATA5 IRX4 MEGF8 WNT3A PCSK6 LRP4 COBL | 6.42e-05 | 526 | 103 | 11 | GO:0007389 |
| GeneOntologyBiologicalProcess | circulatory system development | PCSK5 ERBB4 RPGRIP1L THSD7A HYAL1 SPEG GATA6 CARD10 NDP GATA5 ZFPM1 IRX4 STAB1 MEGF8 ADAMTS6 ADAMTS9 LOXL2 WNT3A NOTCH4 | 8.53e-05 | 1442 | 103 | 19 | GO:0072359 |
| GeneOntologyCellularComponent | extracellular matrix | WNT6 NTN3 NDP ADAMTSL3 SSPOP ADAMTS10 ENAM SNED1 FBLN1 FCGBP MEGF6 ADAMTS6 ADAMTS9 LOXL2 PCSK6 ADAMTS16 ADAMTS20 FBN3 | 2.68e-09 | 656 | 102 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | WNT6 NTN3 NDP ADAMTSL3 SSPOP ADAMTS10 ENAM SNED1 FBLN1 FCGBP MEGF6 ADAMTS6 ADAMTS9 LOXL2 PCSK6 ADAMTS16 ADAMTS20 FBN3 | 2.81e-09 | 658 | 102 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NTN3 NDP SSPOP ADAMTS10 FBLN1 MEGF6 ADAMTS9 LOXL2 PCSK6 ADAMTS20 | 2.66e-04 | 530 | 102 | 10 | GO:0062023 |
| MousePheno | abnormal heart atrium morphology | 7.56e-06 | 232 | 81 | 9 | MP:0003105 | |
| MousePheno | atrial septal defect | 1.16e-05 | 88 | 81 | 6 | MP:0010403 | |
| MousePheno | abnormal interatrial septum morphology | 3.56e-05 | 107 | 81 | 6 | MP:0000282 | |
| MousePheno | muscular ventricular septal defect | 8.22e-05 | 77 | 81 | 5 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 9.29e-05 | 79 | 81 | 5 | MP:0010498 | |
| MousePheno | abnormal heart right atrium morphology | 1.30e-04 | 45 | 81 | 4 | MP:0003922 | |
| MousePheno | abnormal interventricular septum morphology | 1.57e-04 | 342 | 81 | 9 | MP:0000281 | |
| MousePheno | absent sacral vertebrae | 1.97e-04 | 4 | 81 | 2 | MP:0004656 | |
| MousePheno | dextrocardia | 2.13e-04 | 51 | 81 | 4 | MP:0000644 | |
| MousePheno | double outlet right ventricle | 2.31e-04 | 150 | 81 | 6 | MP:0000284 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 2.67e-04 | 22 | 81 | 3 | MP:0001073 | |
| Domain | EGF | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 DNER CLEC18C STAB1 SNED1 FBLN1 FCGBP MEGF6 MEGF8 PCSK6 LRP4 ADGRE5 FBN3 NOTCH4 | 4.80e-16 | 235 | 101 | 18 | SM00181 |
| Domain | EGF-like_dom | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 DNER CLEC18C STAB1 SNED1 FBLN1 FCGBP MEGF6 MEGF8 PCSK6 LRP4 ADGRE5 FBN3 NOTCH4 | 1.33e-15 | 249 | 101 | 18 | IPR000742 |
| Domain | EGF_1 | HGFAC CLEC18A CLEC18B HYAL1 NTN3 DNER CLEC18C SSPOP ITGB7 STAB1 SNED1 FBLN1 MEGF6 MEGF8 LRP4 FBN3 NOTCH4 | 3.36e-14 | 255 | 101 | 17 | PS00022 |
| Domain | EGF_2 | HGFAC CLEC18A CLEC18B HYAL1 NTN3 DNER CLEC18C SSPOP ITGB7 STAB1 SNED1 FBLN1 MEGF6 MEGF8 LRP4 FBN3 NOTCH4 | 6.31e-14 | 265 | 101 | 17 | PS01186 |
| Domain | Growth_fac_rcpt_ | PCSK5 ELAPOR2 ERBB4 NTN3 DNER STAB1 FBLN1 MEGF6 MEGF8 PCSK6 LRP4 ADGRE5 FBN3 NOTCH4 | 1.22e-13 | 156 | 101 | 14 | IPR009030 |
| Domain | EGF_3 | HGFAC CLEC18A CLEC18B HYAL1 DNER CLEC18C SSPOP STAB1 SNED1 FBLN1 MEGF6 MEGF8 LRP4 ADGRE5 FBN3 NOTCH4 | 1.47e-13 | 235 | 101 | 16 | PS50026 |
| Domain | EGF-like_CS | HGFAC CLEC18A CLEC18B HYAL1 NTN3 DNER CLEC18C ITGB7 STAB1 SNED1 FBLN1 MEGF6 MEGF8 LRP4 FBN3 NOTCH4 | 7.40e-13 | 261 | 101 | 16 | IPR013032 |
| Domain | PLAC | 6.24e-11 | 14 | 101 | 6 | PF08686 | |
| Domain | PLAC | 5.51e-10 | 19 | 101 | 6 | PS50900 | |
| Domain | PLAC | 5.51e-10 | 19 | 101 | 6 | IPR010909 | |
| Domain | EGF_CA | 1.13e-09 | 122 | 101 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.33e-09 | 124 | 101 | 10 | IPR001881 | |
| Domain | TSP_1 | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 1.67e-09 | 63 | 101 | 8 | PF00090 |
| Domain | TSP1 | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 2.16e-09 | 65 | 101 | 8 | SM00209 |
| Domain | TSP1_rpt | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 2.16e-09 | 65 | 101 | 8 | IPR000884 |
| Domain | TSP1 | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 2.16e-09 | 65 | 101 | 8 | PS50092 |
| Domain | EGF_Ca-bd_CS | 2.65e-09 | 97 | 101 | 9 | IPR018097 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.68e-09 | 24 | 101 | 6 | IPR013273 | |
| Domain | EGF_CA | 3.19e-09 | 99 | 101 | 9 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.48e-09 | 100 | 101 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.86e-09 | 106 | 101 | 9 | IPR000152 | |
| Domain | ADAM_spacer1 | 1.30e-07 | 23 | 101 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.30e-07 | 23 | 101 | 5 | PF05986 | |
| Domain | hEGF | 3.73e-07 | 28 | 101 | 5 | PF12661 | |
| Domain | EGF | 4.10e-07 | 126 | 101 | 8 | PF00008 | |
| Domain | EGF_CA | 4.15e-07 | 86 | 101 | 7 | PF07645 | |
| Domain | - | 1.05e-06 | 15 | 101 | 4 | 3.40.33.10 | |
| Domain | CAP | 1.05e-06 | 15 | 101 | 4 | PF00188 | |
| Domain | CAP_domain | 1.05e-06 | 15 | 101 | 4 | IPR014044 | |
| Domain | SCP | 1.05e-06 | 15 | 101 | 4 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 1.05e-06 | 15 | 101 | 4 | IPR001283 | |
| Domain | Peptidase_M12B_N | 2.08e-06 | 39 | 101 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.08e-06 | 39 | 101 | 5 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.37e-06 | 40 | 101 | 5 | PS00427 | |
| Domain | Reprolysin | 2.37e-06 | 40 | 101 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 2.37e-06 | 40 | 101 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.37e-06 | 40 | 101 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 2.37e-06 | 40 | 101 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 2.69e-06 | 41 | 101 | 5 | IPR001762 | |
| Domain | GF_recep_IV | 3.03e-06 | 6 | 101 | 3 | PF14843 | |
| Domain | GF_recep_IV | 3.03e-06 | 6 | 101 | 3 | IPR032778 | |
| Domain | Fol_N | 2.45e-05 | 11 | 101 | 3 | IPR003645 | |
| Domain | FOLN | 2.45e-05 | 11 | 101 | 3 | SM00274 | |
| Domain | Pept_M12B_GON-ADAMTSs | 2.90e-05 | 2 | 101 | 2 | IPR012314 | |
| Domain | GON | 2.90e-05 | 2 | 101 | 2 | PF08685 | |
| Domain | GON | 2.90e-05 | 2 | 101 | 2 | PS51046 | |
| Domain | Laminin_EGF | 3.71e-05 | 35 | 101 | 4 | PF00053 | |
| Domain | EGF_Lam | 3.71e-05 | 35 | 101 | 4 | SM00180 | |
| Domain | Laminin_EGF | 5.16e-05 | 38 | 101 | 4 | IPR002049 | |
| Domain | MetalloPept_cat_dom | 7.74e-05 | 81 | 101 | 5 | IPR024079 | |
| Domain | - | 7.74e-05 | 81 | 101 | 5 | 3.40.390.10 | |
| Domain | GATA_N | 8.66e-05 | 3 | 101 | 2 | IPR008013 | |
| Domain | GATA-N | 8.66e-05 | 3 | 101 | 2 | PF05349 | |
| Domain | Furin_repeat | 1.18e-04 | 18 | 101 | 3 | IPR006212 | |
| Domain | FU | 1.18e-04 | 18 | 101 | 3 | SM00261 | |
| Domain | ZINC_PROTEASE | 1.91e-04 | 98 | 101 | 5 | PS00142 | |
| Domain | EPHD | 2.19e-04 | 22 | 101 | 3 | PS51805 | |
| Domain | EGF_extracell | 3.11e-04 | 60 | 101 | 4 | IPR013111 | |
| Domain | EGF_2 | 3.11e-04 | 60 | 101 | 4 | PF07974 | |
| Domain | cEGF | 3.65e-04 | 26 | 101 | 3 | IPR026823 | |
| Domain | cEGF | 3.65e-04 | 26 | 101 | 3 | PF12662 | |
| Domain | Peptidase_S8_Asp-AS | 4.28e-04 | 6 | 101 | 2 | IPR023827 | |
| Domain | ZnF_U1 | 5.06e-04 | 29 | 101 | 3 | SM00451 | |
| Domain | Znf_U1 | 5.06e-04 | 29 | 101 | 3 | IPR003604 | |
| Domain | EGF_LAM_2 | 5.60e-04 | 30 | 101 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.60e-04 | 30 | 101 | 3 | PS01248 | |
| Domain | PrprotnconvertsP | 5.97e-04 | 7 | 101 | 2 | IPR002884 | |
| Domain | P_proprotein | 5.97e-04 | 7 | 101 | 2 | PF01483 | |
| Domain | S8_pro-domain | 5.97e-04 | 7 | 101 | 2 | IPR032815 | |
| Domain | - | 5.97e-04 | 7 | 101 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 5.97e-04 | 7 | 101 | 2 | PF16470 | |
| Domain | Peptidase_S8_His-AS | 1.02e-03 | 9 | 101 | 2 | IPR022398 | |
| Domain | Integin_beta_N | 1.02e-03 | 9 | 101 | 2 | IPR033760 | |
| Domain | Peptidase_S8_Ser-AS | 1.02e-03 | 9 | 101 | 2 | IPR023828 | |
| Domain | PSI_integrin | 1.02e-03 | 9 | 101 | 2 | PF17205 | |
| Domain | TYR_PHOSPHATASE_1 | 1.22e-03 | 86 | 101 | 4 | PS00383 | |
| Domain | Peptidase_S8_subtilisin-rel | 1.27e-03 | 10 | 101 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 1.27e-03 | 10 | 101 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 1.27e-03 | 10 | 101 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 1.27e-03 | 10 | 101 | 2 | PS00138 | |
| Domain | TYR_PHOSPHATASE_2 | 1.27e-03 | 87 | 101 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.27e-03 | 87 | 101 | 4 | IPR000387 | |
| Domain | - | 1.54e-03 | 11 | 101 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 1.54e-03 | 11 | 101 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 1.54e-03 | 11 | 101 | 2 | PF00082 | |
| Domain | - | 1.56e-03 | 92 | 101 | 4 | 3.90.190.10 | |
| Domain | C-type_lectin_CS | 1.62e-03 | 43 | 101 | 3 | IPR018378 | |
| Domain | Galactose-bd-like | 1.69e-03 | 94 | 101 | 4 | IPR008979 | |
| Domain | EGF_3 | 1.84e-03 | 12 | 101 | 2 | PF12947 | |
| Domain | TIL | 1.84e-03 | 12 | 101 | 2 | PF01826 | |
| Domain | ZnF_GATA | 1.84e-03 | 12 | 101 | 2 | SM00401 | |
| Domain | EGF_dom | 1.84e-03 | 12 | 101 | 2 | IPR024731 | |
| Domain | C8 | 1.84e-03 | 12 | 101 | 2 | PF08742 | |
| Domain | - | 1.90e-03 | 97 | 101 | 4 | 3.10.100.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.05e-03 | 99 | 101 | 4 | IPR029021 | |
| Domain | C-type_lectin-like/link | 2.05e-03 | 99 | 101 | 4 | IPR016186 | |
| Domain | Unchr_dom_Cys-rich | 2.17e-03 | 13 | 101 | 2 | IPR014853 | |
| Domain | C8 | 2.17e-03 | 13 | 101 | 2 | SM00832 | |
| Domain | TIL_dom | 2.53e-03 | 14 | 101 | 2 | IPR002919 | |
| Domain | CTDL_fold | 2.72e-03 | 107 | 101 | 4 | IPR016187 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 1.18e-11 | 39 | 69 | 8 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 1.18e-11 | 39 | 69 | 8 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 NOTCH4 | 3.68e-11 | 68 | 69 | 9 | M27303 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 NOTCH4 | 2.98e-08 | 143 | 69 | 9 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 5.57e-08 | 109 | 69 | 8 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 6.43e-08 | 111 | 69 | 8 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD7A HYAL1 ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 NOTCH4 | 3.49e-07 | 250 | 69 | 10 | M27554 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.43e-04 | 300 | 69 | 7 | M610 | |
| Pubmed | THSD7A ADAMTSL3 SSPOP ADAMTS10 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS20 | 7.51e-11 | 75 | 105 | 8 | 20637190 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 2.67e-08 | 3 | 105 | 3 | 26170455 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 2.67e-08 | 3 | 105 | 3 | 33603190 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 16709836 | ||
| Pubmed | 1.81e-07 | 17 | 105 | 4 | 22183742 | ||
| Pubmed | 1.64e-06 | 118 | 105 | 6 | 21078624 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 9693030 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 11167130 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 5.35e-06 | 38 | 105 | 4 | 18267097 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 5.77e-06 | 12 | 105 | 3 | 25770910 | |
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 9.03e-06 | 2 | 105 | 2 | 11941487 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18061232 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12514189 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8335106 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33174041 | ||
| Pubmed | Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome. | 9.03e-06 | 2 | 105 | 2 | 31816409 | |
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 9.03e-06 | 2 | 105 | 2 | 27779234 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8468318 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.26e-05 | 168 | 105 | 6 | 30631154 | |
| Pubmed | 1.37e-05 | 100 | 105 | 5 | 24859004 | ||
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 30579834 | ||
| Pubmed | The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma. | 2.70e-05 | 3 | 105 | 2 | 31322171 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16162334 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24753090 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 8670066 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 9566909 | ||
| Pubmed | Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. | 2.70e-05 | 3 | 105 | 2 | 11063880 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 37169079 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24367609 | ||
| Pubmed | GATA6 and FOXA2 regulate Wnt6 expression during extraembryonic endoderm formation. | 2.70e-05 | 3 | 105 | 2 | 22607194 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 9119112 | ||
| Pubmed | 2.94e-05 | 20 | 105 | 3 | 19922873 | ||
| Pubmed | Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. | 2.94e-05 | 20 | 105 | 3 | 11245568 | |
| Pubmed | 3.42e-05 | 21 | 105 | 3 | 19806668 | ||
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 3.42e-05 | 21 | 105 | 3 | 11914369 | |
| Pubmed | 4.53e-05 | 23 | 105 | 3 | 29567669 | ||
| Pubmed | 5.17e-05 | 24 | 105 | 3 | 21633169 | ||
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 5.40e-05 | 4 | 105 | 2 | 16829522 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 24179092 | ||
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | 5.40e-05 | 4 | 105 | 2 | 8615794 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 12787574 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 16507336 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 11375995 | ||
| Pubmed | Wnt2 is a direct downstream target of GATA6 during early cardiogenesis. | 5.40e-05 | 4 | 105 | 2 | 16621466 | |
| Pubmed | BMP-mediated induction of GATA4/5/6 blocks somitic responsiveness to SHH. | 5.40e-05 | 4 | 105 | 2 | 25294942 | |
| Pubmed | The proprotein convertases furin and PACE4 play a significant role in tumor progression. | 5.40e-05 | 4 | 105 | 2 | 10900462 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 12944489 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18697834 | ||
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 5.40e-05 | 4 | 105 | 2 | 9521771 | |
| Pubmed | 6.61e-05 | 26 | 105 | 3 | 24415953 | ||
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 8.97e-05 | 5 | 105 | 2 | 29625437 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 9356179 | ||
| Pubmed | Genome-wide association study identifies two susceptibility loci for osteosarcoma. | 8.97e-05 | 5 | 105 | 2 | 23727862 | |
| Pubmed | Common variants at 12q14 and 12q24 are associated with hippocampal volume. | 8.97e-05 | 5 | 105 | 2 | 22504421 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 31600785 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 18664504 | ||
| Pubmed | Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. | 8.97e-05 | 5 | 105 | 2 | 9242664 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 11380615 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 22562232 | ||
| Pubmed | 1.05e-04 | 153 | 105 | 5 | 10718198 | ||
| Pubmed | NOTCH maintains developmental cardiac gene network through WNT5A. | 1.24e-04 | 32 | 105 | 3 | 30347193 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 15539431 | ||
| Pubmed | Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. | 1.34e-04 | 6 | 105 | 2 | 7556445 | |
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 1.34e-04 | 6 | 105 | 2 | 16691565 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 8940009 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 9291583 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 16135528 | ||
| Pubmed | 1.37e-04 | 33 | 105 | 3 | 20301623 | ||
| Pubmed | 1.63e-04 | 35 | 105 | 3 | 30940800 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 15987774 | ||
| Pubmed | WNT-3a modulates platelet function by regulating small GTPase activity. | 1.88e-04 | 7 | 105 | 2 | 22705156 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 10409610 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 7819324 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 18212046 | ||
| Pubmed | 1.93e-04 | 37 | 105 | 3 | 22432025 | ||
| Pubmed | Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | 1.93e-04 | 37 | 105 | 3 | 18800919 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.46e-04 | 100 | 105 | 4 | 25807483 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 7782070 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 2.50e-04 | 8 | 105 | 2 | 9885250 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 10037747 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 21041365 | ||
| Pubmed | The secreted metalloprotease ADAMTS20 is required for melanoblast survival. | 2.50e-04 | 8 | 105 | 2 | 18454205 | |
| Pubmed | Gata6 restricts Isl1 to the posterior of nascent hindlimb buds through Isl1 cis-regulatory modules. | 2.50e-04 | 8 | 105 | 2 | 29197504 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 14662776 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DPYSL2 DNER WDR25 MSRB3 FBLN1 TXNDC5 MEGF8 LOXL2 SCAPER RNFT1 LRP4 ADGRE5 | 2.77e-04 | 1201 | 105 | 12 | 35696571 |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 3.11e-04 | 424 | 105 | 7 | 21731673 | |
| Pubmed | Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals. | 3.21e-04 | 9 | 105 | 2 | 20501701 | |
| Pubmed | The activation and physiological functions of the proprotein convertases. | 3.21e-04 | 9 | 105 | 2 | 18343183 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 12122015 | ||
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 3.21e-04 | 9 | 105 | 2 | 21805236 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 3.21e-04 | 9 | 105 | 2 | 22679642 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 9738004 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 23775089 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 8698813 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 20498066 | ||
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 10364163 | ||
| Pubmed | Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. | 4.00e-04 | 10 | 105 | 2 | 8275860 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 16163737 | ||
| Interaction | CYSRT1 interactions | PCSK5 CLEC18A RALGDS KRTAP13-3 CCDC187 CARD10 GATA5 WDR25 IQCN ADAMTSL3 ZNF835 ZFHX2 | 7.76e-06 | 511 | 99 | 12 | int:CYSRT1 |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.11e-08 | 19 | 74 | 5 | 50 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 5.84e-04 | 9 | 74 | 2 | 973 | |
| GeneFamily | C-type lectin domain family | 9.38e-04 | 47 | 74 | 3 | 494 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.68e-03 | 15 | 74 | 2 | 82 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF354A ZNF618 ZNF316 ZNF407 ZFPM1 ZNF835 SCAPER ZFHX2 PLAGL1 | 2.57e-03 | 718 | 74 | 9 | 28 |
| GeneFamily | Wnt family|Endogenous ligands | 2.70e-03 | 19 | 74 | 2 | 360 | |
| Coexpression | NABA_MATRISOME | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 WNT6 NTN3 CLEC18C FLG2 ADAMTSL3 SSPOP ADAMTS10 SNED1 FBLN1 MEGF6 MEGF8 ADAMTS6 ADAMTS9 LOXL2 WNT3A PCSK6 ADAMTS16 ADAMTS20 FBN3 | 1.88e-12 | 1026 | 105 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 WNT6 NTN3 CLEC18C FLG2 ADAMTSL3 SSPOP ADAMTS10 SNED1 FBLN1 MEGF6 MEGF8 ADAMTS6 ADAMTS9 LOXL2 WNT3A PCSK6 ADAMTS16 ADAMTS20 | 9.72e-12 | 1008 | 105 | 23 | MM17056 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 WNT6 CLEC18C FLG2 ADAMTSL3 ADAMTS10 MEGF6 MEGF8 ADAMTS6 ADAMTS9 LOXL2 WNT3A PCSK6 ADAMTS16 ADAMTS20 | 1.05e-10 | 738 | 105 | 19 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 HGFAC CLEC18A CLEC18B HYAL1 WNT6 CLEC18C FLG2 ADAMTSL3 ADAMTS10 MEGF6 MEGF8 ADAMTS6 ADAMTS9 LOXL2 WNT3A PCSK6 ADAMTS16 ADAMTS20 | 1.41e-10 | 751 | 105 | 19 | M5885 |
| Coexpression | NABA_ECM_REGULATORS | PCSK5 HYAL1 ADAMTSL3 ADAMTS10 ADAMTS6 ADAMTS9 LOXL2 PCSK6 ADAMTS16 ADAMTS20 | 4.28e-08 | 238 | 105 | 10 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | PCSK5 HYAL1 ADAMTSL3 ADAMTS10 ADAMTS6 ADAMTS9 LOXL2 PCSK6 ADAMTS16 ADAMTS20 | 5.01e-08 | 242 | 105 | 10 | MM17062 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | FNDC3B DPYSL2 THSD7A SPEG CARD10 DCAF5 PREX2 MSRB3 LOXL2 RNFT1 ADAMTS16 AGFG1 ADGRE5 NOTCH4 | 8.03e-06 | 854 | 105 | 14 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | FNDC3B DPYSL2 THSD7A SPEG CARD10 DCAF5 PREX2 MSRB3 LOXL2 RNFT1 ADAMTS16 AGFG1 ADGRE5 NOTCH4 | 1.25e-05 | 888 | 105 | 14 | MM1018 |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.86e-05 | 204 | 105 | 7 | MM966 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 7.11e-05 | 173 | 105 | 6 | M650 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 1.01e-04 | 115 | 105 | 5 | M45752 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 1.16e-04 | 189 | 105 | 6 | M45678 | |
| Coexpression | GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN | 1.37e-04 | 195 | 105 | 6 | M5142 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL | 1.45e-04 | 124 | 105 | 5 | M45673 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 1.57e-04 | 200 | 105 | 6 | M5980 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN | 1.57e-04 | 200 | 105 | 6 | M2917 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 1.62e-04 | 201 | 105 | 6 | MM17086 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | CLEC18A ERBB4 CLEC18B WNT6 NTN3 GATA6 CLEC18C GATA5 LHX9 ADAMTS9 WNT3A | 4.24e-06 | 416 | 100 | 11 | ratio_EB_vs_SC_1000_K5 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | ELAPOR2 CARD10 ADAMTSL3 STAB1 SNED1 TXNDC5 OTOF ADAMTS6 LOXL2 NOTCH4 | 3.43e-05 | 428 | 100 | 10 | JC_hmvEC_1000_K4 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | CLEC18A CLEC18B WNT6 DNER CLEC18C GATA5 LHX9 WNT3A ADAMTS20 FBN3 | 3.78e-05 | 433 | 100 | 10 | Arv_EB-LF_1000_K4 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 5.13e-05 | 204 | 100 | 7 | ratio_EB_vs_SC_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_200 | 6.57e-05 | 17 | 100 | 3 | gudmap_developingGonad_e12.5_testes_k1_200 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 1.11e-04 | 100 | 100 | 5 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | CLEC18A CLEC18B WNT6 DNER GATA5 LHX9 WNT3A ADAMTS16 ADAMTS20 FBN3 | 1.17e-04 | 496 | 100 | 10 | PCBC_EB_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | ERBB4 CLEC18B WNT6 GATA6 GATA5 LHX9 MSRB3 ADAMTS9 WNT3A PLAGL1 | 1.21e-04 | 498 | 100 | 10 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 1.22e-04 | 102 | 100 | 5 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | HGFAC CLEC18A ERBB4 CLEC18B WNT6 NTN3 DNER CLEC18C GATA5 SSPOP LHX9 ADAMTS6 ADAMTS9 WNT3A PLAGL1 | 1.80e-04 | 1094 | 100 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | CLEC18A ERBB4 THSD7A CLEC18B WNT6 NTN3 GATA6 CLEC18C GATA5 LHX9 MSRB3 ADAMTS9 WNT3A PLAGL1 | 2.29e-04 | 994 | 100 | 14 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 2.74e-04 | 189 | 100 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | THSD7A SPEG DUSP2 NTN3 CARD10 GATA5 R3HDML STAB1 SNED1 FBLN1 ADAMTS9 PTRH1 ADAMTS16 PLAGL1 NOTCH4 | 2.88e-04 | 1143 | 100 | 15 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 3.54e-04 | 279 | 100 | 7 | ratio_ECTO_vs_SC_500_K1 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | CLEC18A CLEC18B WNT6 CLEC18C CAMK1G SSPOP LHX9 ADAMTS9 WNT3A | 3.85e-04 | 471 | 100 | 9 | ratio_ECTO_vs_SC_1000_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | DPYSL2 RPGRIP1L ZNF618 GATA6 LHX9 ADAMTS9 TKT PCSK6 ADAMTS16 ADGRE5 KLHL8 C9orf72 | 3.92e-04 | 803 | 100 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 3.93e-04 | 73 | 100 | 4 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 3.93e-04 | 73 | 100 | 4 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 3.94e-04 | 284 | 100 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.55e-08 | 200 | 105 | 8 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-07 | 182 | 105 | 7 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-07 | 185 | 105 | 7 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 3.09e-07 | 187 | 105 | 7 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-07 | 188 | 105 | 7 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-07 | 190 | 105 | 7 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-07 | 191 | 105 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-07 | 192 | 105 | 7 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-07 | 192 | 105 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-07 | 192 | 105 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 3.83e-07 | 193 | 105 | 7 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-07 | 197 | 105 | 7 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-07 | 200 | 105 | 7 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-07 | 200 | 105 | 7 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-07 | 200 | 105 | 7 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.84e-06 | 167 | 105 | 6 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-06 | 173 | 105 | 6 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-06 | 175 | 105 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-06 | 178 | 105 | 6 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 178 | 105 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-06 | 179 | 105 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-06 | 179 | 105 | 6 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-06 | 179 | 105 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.51e-06 | 181 | 105 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.51e-06 | 181 | 105 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.51e-06 | 181 | 105 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.66e-06 | 182 | 105 | 6 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-06 | 182 | 105 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-06 | 182 | 105 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-06 | 183 | 105 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-06 | 183 | 105 | 6 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-06 | 183 | 105 | 6 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.96e-06 | 184 | 105 | 6 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 185 | 105 | 6 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 185 | 105 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 185 | 105 | 6 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 185 | 105 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 105 | 6 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.44e-06 | 187 | 105 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 105 | 6 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.61e-06 | 188 | 105 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-06 | 190 | 105 | 6 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 5.96e-06 | 190 | 105 | 6 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-06 | 190 | 105 | 6 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 190 | 105 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-06 | 190 | 105 | 6 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 190 | 105 | 6 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-06 | 190 | 105 | 6 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-06 | 191 | 105 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-06 | 191 | 105 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-06 | 191 | 105 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 192 | 105 | 6 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-06 | 192 | 105 | 6 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-06 | 192 | 105 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 192 | 105 | 6 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.52e-06 | 193 | 105 | 6 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.92e-06 | 195 | 105 | 6 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.12e-06 | 196 | 105 | 6 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 198 | 105 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| ToppCell | Skin-Endothelial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.77e-06 | 199 | 105 | 6 | 6b3ef5d8f87cdfe5401d05f19339ddfcd9cda476 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-1|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.30e-06 | 119 | 105 | 5 | 5d5fcddb5723e7a94bfcf56e165a980fa450b789 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.19e-05 | 142 | 105 | 5 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.42e-05 | 145 | 105 | 5 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.67e-05 | 148 | 105 | 5 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.13e-05 | 153 | 105 | 5 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.54e-05 | 157 | 105 | 5 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 161 | 105 | 5 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 161 | 105 | 5 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 162 | 105 | 5 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 162 | 105 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 4.48e-05 | 165 | 105 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.61e-05 | 166 | 105 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.61e-05 | 166 | 105 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 4.88e-05 | 168 | 105 | 5 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | droplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 169 | 105 | 5 | 2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 169 | 105 | 5 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-05 | 170 | 105 | 5 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-05 | 170 | 105 | 5 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 171 | 105 | 5 | dbffd55db0b3fc6eeb38d05189d84653f0111b31 | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 171 | 105 | 5 | eee1199332c09aaae021134ee7c91661b11df50a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 172 | 105 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 172 | 105 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 5.46e-05 | 172 | 105 | 5 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 5.61e-05 | 173 | 105 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 88 | 105 | 4 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 174 | 105 | 5 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 176 | 105 | 5 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 176 | 105 | 5 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-05 | 177 | 105 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| Disease | hippocampal volume, brain volume measurement | 3.47e-05 | 3 | 101 | 2 | EFO_0005035, EFO_0006930 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.76e-05 | 58 | 101 | 4 | C0002736 | |
| Disease | waist-hip ratio | PCSK5 FNDC3B HCAR2 ERBB4 ZNF407 IQCN ADAMTSL3 STAB1 MSRB3 ADAMTS10 MEGF8 ADAMTS6 ADAMTS9 ADAMTS20 | 7.45e-05 | 1226 | 101 | 14 | EFO_0004343 |
| Disease | Klatskin's tumor (is_implicated_in) | 1.15e-04 | 5 | 101 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | scoliosis (implicated_via_orthology) | 1.15e-04 | 5 | 101 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | erythronate measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0021025 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain h4 measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0020481 | |
| Disease | FEV/FEC ratio | PCSK5 FNDC3B SPEG DNER GATA6 GATA5 ADAMTSL3 MSRB3 FBLN1 FCGBP MEGF6 SCAPER MYL10 | 2.87e-04 | 1228 | 101 | 13 | EFO_0004713 |
| Disease | Ventricular Septal Defects | 3.20e-04 | 8 | 101 | 2 | C0018818 | |
| Disease | central serous retinopathy | 3.20e-04 | 8 | 101 | 2 | EFO_0009784 | |
| Disease | granule cell layer dentate gyrus volume | 3.20e-04 | 8 | 101 | 2 | EFO_0009403 | |
| Disease | osteosarcoma | 3.20e-04 | 8 | 101 | 2 | EFO_0000637 | |
| Disease | hippocampal amigdala transition area volume | 6.25e-04 | 11 | 101 | 2 | EFO_0009401 | |
| Disease | antihyperlipidemic drug use measurement | 6.68e-04 | 115 | 101 | 4 | EFO_0803367 | |
| Disease | central corneal thickness | 6.92e-04 | 309 | 101 | 6 | EFO_0005213 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 8.34e-04 | 122 | 101 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | obesity (implicated_via_orthology) | 8.81e-04 | 215 | 101 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | tetralogy of Fallot (is_implicated_in) | 8.83e-04 | 13 | 101 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | corneal resistance factor | 9.31e-04 | 451 | 101 | 7 | EFO_0010067 | |
| Disease | ventricular septal defect (is_implicated_in) | 1.03e-03 | 14 | 101 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | Malignant neoplasm of skin | 1.10e-03 | 59 | 101 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.10e-03 | 59 | 101 | 3 | C0037286 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.33e-03 | 63 | 101 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Tetralogy of Fallot | 1.35e-03 | 16 | 101 | 2 | C0039685 | |
| Disease | high altitude adaptation | 1.53e-03 | 17 | 101 | 2 | EFO_0009105 | |
| Disease | Amyotrophic lateral sclerosis | 1.53e-03 | 17 | 101 | 2 | cv:C0002736 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.17e-03 | 264 | 101 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | feeling "fed-up" measurement | 2.28e-03 | 76 | 101 | 3 | EFO_0009588 | |
| Disease | amino acid measurement | 2.31e-03 | 678 | 101 | 8 | EFO_0005134 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.56e-03 | 22 | 101 | 2 | C1843687 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.64e-03 | 80 | 101 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Headache, type 2 diabetes mellitus | 2.80e-03 | 23 | 101 | 2 | HP_0002315, MONDO_0005148 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 3.05e-03 | 24 | 101 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | response to anticonvulsant | 3.14e-03 | 85 | 101 | 3 | GO_0036277 | |
| Disease | Schizophrenia | 3.32e-03 | 883 | 101 | 9 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSARGHNGVRSCISC | 136 | Q86Y79 | |
| RTGAHSRGSVCSVCG | 86 | A0A494C0Y3 | |
| RTGAHSRGSVCSVCG | 86 | A0A494C0N9 | |
| TLVSTNGSSGCGRCH | 176 | Q15303 | |
| GGTCLKACASSHSLC | 456 | Q9BWT7 | |
| GRLSCSSGGHDVCVS | 116 | A0A096LP49 | |
| RRSNCTNHCDLGDTS | 221 | Q5VTM2 | |
| FAAVSRGCCTSLTHL | 421 | Q6F5E8 | |
| LGSKNGSTTCQCSHL | 516 | P48960 | |
| LCTHGTCRNTVGSFH | 996 | Q75N90 | |
| RTCGGGVSSSSRHCD | 561 | Q9H324 | |
| TCGGGVSHRSRLCTN | 601 | Q8TE57 | |
| CSSSCSGGLQHRAVV | 1316 | P59510 | |
| SRTCGGGVSSSLRHC | 571 | Q9UKP5 | |
| DGLIHNSGDCRSSTC | 86 | P25092 | |
| ACSVCHSLSSRIGSP | 1041 | Q9H0B3 | |
| NSLSTCCESGGRTLA | 21 | P78413 | |
| SCSGSGDSGRRSHAC | 266 | Q5D862 | |
| LGCSSAISAHCNFRL | 1106 | Q68CZ1 | |
| RGSGSATCSLCHGSK | 201 | A6NFK2 | |
| LSCGDLQVTGSAHCT | 321 | Q16555 | |
| NGGANLCSSFSICHT | 171 | Q8TDS4 | |
| CSRCLCQHLLSGGSG | 76 | Q8NFR9 | |
| LHCTGNEATLAACTS | 126 | Q9Y4K0 | |
| HCQAGISRSATICLA | 256 | Q05923 | |
| HNCTECRDGLSLQGS | 751 | Q92824 | |
| GFTQLGTSCITNHTC | 921 | P29122 | |
| SVSHCRAGAGVAVCS | 586 | Q9P2G9 | |
| CSTCNKTLTTGDHFG | 161 | Q9NQ69 | |
| LSGVCHSCGFISTTR | 346 | Q8IX07 | |
| NSSLTGTLLHKDCCG | 871 | Q96JK2 | |
| CLTSATCHLRQGGAH | 866 | Q7Z7M0 | |
| ISAHCNLCLTGSSNS | 71 | Q9BUA6 | |
| HCTAQLCASLALGSA | 96 | Q8NGU4 | |
| RHTACLSSPCLNGGT | 241 | Q04756 | |
| ASSCRACALGSEQSG | 601 | A8MWY0 | |
| GRCSCSGQSSGHLCE | 546 | P26010 | |
| GSSHCRAGQTGVCLI | 461 | Q96NX5 | |
| TARESHACLACSCNG | 301 | O00634 | |
| ITGSHSCRLGESCIN | 221 | P23142 | |
| SRRAGLCCTNCHTTN | 236 | Q9BWX5 | |
| SSRRLGLSCANCHTT | 436 | Q92908 | |
| CGSSGTHLACSSLRS | 261 | Q7L622 | |
| SSCSVSCGRGHKQRN | 1451 | Q9P2N4 | |
| TRTCQGSCAALSGLT | 5131 | Q9Y6R7 | |
| RACCISTGGHSQCSE | 646 | Q53EP0 | |
| SALLAAIRGHSGTCS | 1151 | O75128 | |
| GESCLVHCLAGVSRS | 81 | Q9NRW4 | |
| SGSSHSKSCDQLRCG | 681 | Q12967 | |
| HVGSRGFGSNSCCSL | 96 | Q3SY46 | |
| SGCHLRSAPCDLGAS | 41 | Q96FQ7 | |
| LLCSQALCSGHGRCV | 356 | Q12794 | |
| FHLSQRGSCCAGSST | 866 | Q9NRM1 | |
| CRNGATCISSLSGFT | 401 | Q8NFT8 | |
| ELSCRNGGSHKSSCE | 251 | Q96BU1 | |
| ASSLLGHCSQVSCES | 1251 | Q9BY12 | |
| SHLQTCGCSVVVGSS | 226 | Q96LT7 | |
| SSNRLGCAIHTCSSI | 176 | Q9H3Y0 | |
| CRVLCNGGSSSHSTG | 1251 | Q9HC10 | |
| THCSAGIGRSGTLIC | 2406 | Q12923 | |
| HCSAGAGRTGTFCAL | 731 | P18433 | |
| CACSAGRLGLRSSAA | 16 | O00198 | |
| HSADGRCKALSTCGA | 226 | Q8NH37 | |
| SAGHGSCDAISGLCL | 876 | O75095 | |
| ALHAASSGDLTCGVC | 111 | Q9UM63 | |
| GSSQACRSCSSRHLP | 151 | A2VEC9 | |
| SSCSRSCGLGLTFQR | 2511 | A2VEC9 | |
| TLRTSCGNCSCAHGK | 3786 | A2VEC9 | |
| HGLSSLCNLGCVLSN | 161 | Q6UW68 | |
| CSKTCGSGLQHRTRH | 206 | Q9UPZ6 | |
| CGSHGTHRDCSSLRS | 276 | Q9BWX1 | |
| LESHIICCTLSTSGG | 2146 | Q7Z333 | |
| HSRGILRVHTGTCSC | 361 | O15466 | |
| LCLAAALGSAQSGSC | 21 | Q8IXL7 | |
| DVSSLCHNGGLCVDS | 896 | Q99466 | |
| GLALSQGCARCFATS | 21 | Q9BYC2 | |
| RVGGCGHTTSVCLAL | 261 | Q8TER0 | |
| TCSCLSGFTGRRCHL | 296 | Q8TER0 | |
| FGGCSHGSRCLRDST | 31 | P0DP57 | |
| SHCSGESQCRAGELG | 31 | Q9Y4X0 | |
| SFVCTSCSGSLRGLN | 46 | P52594 | |
| SSHCGSRSCSAAAAR | 161 | Q8N6U2 | |
| ATSSQLGCGRHLCSA | 156 | A5D8T8 | |
| ATSSQLGCGRHLCSA | 156 | Q6UXF7 | |
| LGCGRHLCSAGQTAI | 161 | Q6UXF7 | |
| ATSSQLGCGRHLCSA | 156 | Q8NCF0 | |
| HCCGTRRSKTLGQSL | 176 | Q9UL52 | |
| SRNIRSGVHSCAHGC | 96 | Q5M7Z0 | |
| LGSNACLGIGVTCHS | 541 | Q5T7W0 | |
| HQLLGCASGACSRGR | 401 | Q7RTX1 | |
| TGGASGCRRCHATFS | 1666 | Q9C0A1 | |
| SESNINLCGSHCGVS | 406 | P29401 | |
| ALTCTARNRHGTQTC | 1461 | Q15772 | |
| QSAERACCHSTGAGK | 756 | O95235 | |
| ACCHSTGAGKLRQAL | 761 | O95235 | |
| SHTRTECKCHGLSGS | 216 | Q9Y6F9 | |
| RGGCSEHANCLSTGL | 2141 | Q9NY15 | |
| AACANTACSASGVGL | 1496 | Q70Z35 | |
| SCGLLQTEHCLTSGE | 1156 | O95359 | |
| HSISVASCGNIFSCG | 201 | Q7Z5U6 | |
| LLARCEGHCSQASRS | 61 | Q00604 | |
| ACANCGRRFSQSSHL | 916 | A6NFI3 | |
| GTAAICGCSSRHQGS | 131 | P56704 | |
| TCNVSSHGIDGCDLL | 296 | P56704 | |
| HSGQGLILTACSVSC | 201 | Q9BY10 | |
| RCLQCGAAFSHVSSL | 391 | Q9Y2P0 | |
| CTAHSDVCSAQGVRG | 121 | Q8NBS9 | |
| GRQCSLNCISSGCHT | 1216 | Q5VWN6 | |
| LNCISSGCHTSGDSL | 1221 | Q5VWN6 | |
| SCSTSLSGCQRIHSR | 336 | O60765 | |
| GNISRTCSHCGLLAS | 846 | Q9C0G0 | |
| TCSHCGLLASSITNL | 851 | Q9C0G0 | |
| SRACTLQGHTQACVG | 506 | Q64LD2 | |
| LRALLGHCSNSAGST | 1056 | P82987 | |
| SGISQRCSHCTRLGA | 166 | O14686 | |
| ACGRSHFTCAVSALG | 26 | O75096 |